StonvexLoading…
StonvexStonvexStonvexCore line items from AGNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.77B | $4.57B | $4.27B | $4.59B |
Operating Income | $-21.47M | $-18.99M | $522.00K | $16.36M |
Net Income | $-22.71M | $-21.27M | $-8.97M | $15.44M |
EPS (Diluted) | $-0.14 | $-0.14 | $-0.06 | $0.10 |
Total Assets | $442.48M | $390.72M | $385.67M | $381.68M |
Total Liabilities | $199.70M | $185.85M | $141.66M | $132.69M |
Cash & Equivalents | $124.25M | $113.61M | $125.87M | $121.59M |
Free Cash Flow OCF − CapEx | $109.04M | $185.03M | $203.77M | $198.48M |
Shares Outstanding | 161.05M | 154.13M | 154.67M | 152.84M |